Omega-3 Fatty Acids PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Omega-3 Fatty Acids PCD pharma franchise company in India, offering 4 Omega-3 formulations in softgel capsule form as part of its nutraceutical portfolio. All products are manufactured at WHO-GMP certified, DCGI-approved facilities and offered to franchise partners with exclusive district-wise monopoly rights.
What are Omega-3 Fatty Acids?
Omega-3 fatty acids are essential polyunsaturated fats — principally eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) — that the human body cannot synthesise in adequate amounts and must obtain from the diet or supplementation. They are incorporated into cell membranes and serve as precursors to anti-inflammatory signalling molecules. Clinically, Omega-3 supplementation is used to lower elevated serum triglycerides, to support cardiovascular health, and as a nutritional adjunct in pregnancy and infant brain and retinal development, where DHA is a structural component. Further information is available from MedlinePlus.
Available Omega-3 Formulations
The Cafoli Lifecare Omega-3 range comprises 4 formulations, available in the following dosage form:
Brand names, compositions, pack sizes and net rates are shared with registered franchise enquiries. Contact our team for the current Omega-3 price list.
Therapeutic Applications of Omega-3 Fatty Acids
Recommended by clinicians as a supplement or adjunct for:
- Hypertriglyceridaemia and adjunctive lipid management
- Cardiovascular risk reduction, alongside diet and statin therapy
- Nutritional support in pregnancy and lactation (DHA)
- Paediatric nutritional supplementation for brain and retinal development
- General wellness and dietary supplementation in adults
Prescriber specialties: cardiologists, consulting physicians, diabetologists, gynaecologists and paediatricians. Omega-3 supplements are an adjunct to, not a replacement for, prescribed lipid-lowering or cardiac therapy.
Why Omega-3 is a High-Potential Molecule for Distributors
Nutraceuticals are the highest-margin corner of the PCD pharma business, and Omega-3 is the category's most established name. Two structural advantages drive this. First, these products sit outside drug price control and are not exposed to the counter-level generic substitution that steadily compresses margins on scheduled medicines — the net rate a distributor negotiates tends to hold. Second, wellness products are self-repeating: once a patient is started on a daily Omega-3 capsule for cholesterol or pregnancy support, they continue buying it without needing a fresh prescription, so the retention cost after the first sale is close to zero. Demand in India is also being pulled by a genuine trend — rising lipid disorders, greater cardiac awareness and a fast-growing preventive health market. With prescribers spanning cardiology, gynaecology, paediatrics and general practice, Omega-3 is the rare SKU that almost every doctor a franchise partner already calls on can write.
Why Choose Cafoli Lifecare
- Monopoly rights — exclusive district-wise marketing rights for the Omega-3 range
- WHO-GMP certified manufacturing and DCGI-approved products
- Promotional inputs — visual aids, MR bags, prescription pads, samples and reminder cards
- 1000+ franchise partners across India with an on-time dispatch record
- Transparent net rates and dedicated franchise support
References
- MedlinePlus — Drugs, Herbs and Supplements
- PubChem — Eicosapentaenoic acid (EPA) compound record
- PubMed — Omega-3 fatty acids, triglycerides and cardiovascular outcomes
Our formulations of Omega-3 Fatty Acids find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: